ORIGINAL RESEARCH
Published on 08 Apr 2025
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
doi 10.3389/fimmu.2025.1582050
- 1,021 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Reducing Adverse Effects of Cancer Immunotherapy: Volume III
Community Series in Reducing Adverse Effects of Cancer Immunotherapy: Volume III
1,684
Total downloads
6,428
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 18 Mar 2025
Clinical features of nivolumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: retrospective analysis based on case reports
doi 10.3389/fimmu.2025.1563100
- 756 views
ORIGINAL RESEARCH
Published on 07 Mar 2025
Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients
doi 10.3389/fimmu.2025.1540442
- 948 views
SYSTEMATIC REVIEW
Published on 30 Jan 2025
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1528084
- 1,080 views
CASE REPORT
Published on 30 Jan 2025
Diffuse panbronchiolitis as a rare complication of thymectomy and radiation therapy in a patient with thymoma: a case report
doi 10.3389/fonc.2025.1496693
- 508 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: